期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 53, 期 1, 页码 249-255出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00691-08
关键词
-
资金
- Carroll Haas Research Fund
- Michigan Nanotechnology Institute for Medicine and the Biological Sciences
- Cystic Fibrosis Foundation
- National Center of Research Resources of the National Institutes of Health [T32 RR07008]
- NanoBio Corp.
- NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007008] Funding Source: NIH RePORTER
Respiratory tract infection, most often involving opportunistic bacterial species with broad-spectrum antibiotic resistance, is the primary cause of death in persons with cystic fibrosis (CF). Species within the Burkholderia cepacia complex are especially problematic in this patient population. We investigated a novel surfactant-stabilized oil-in-water nanoemulsion (NB-401) for activity against 150 bacterial isolates recovered primarily from CF respiratory tract specimens. These specimens included 75 Burkholderia isolates and 75 isolates belonging to other CF-relevant species including Pseudomonas, Achromobacter, Pandoraea, Ralstonia, Stenotrophomonas, and Acinetobacter. Nearly one-third of the isolates were multidrug resistant, and 20 (13%) were panresistant based on standard antibiotic testing. All isolates belonging to the same species were genotyped to ensure that each isolate was a distinct strain. The MIC90 of NB-401 was 125 mu g/ml. We found no decrease in activity against multidrug-resistant or panresistant strains. MBC testing showed no evidence of tolerance to NB-401. We investigated the activity of NB-401 against a subset of strains grown as a biofilm and against planktonic strains in the presence of CF sputum. Although the activity of NB-401 was decreased under both conditions, the nanoemulsion remained bactericidal for all strains tested. These results support NB-401's potential role as a novel antimicrobial agent for the treatment of infection due to CF-related opportunistic pathogens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据